Zobrazeno 1 - 10
of 64
pro vyhledávání: '"chloroquine/hydroxychloroquine"'
Publikováno v:
Journal of Experimental Pharmacology, Vol Volume 14, Pp 353-365 (2022)
Axel Hage *, Mathis de Vries *, Andreas Leffler, Carsten Stoetzer Department of Anesthesiology and Intensive Care Medicine, Hannover Medical School, Hanover, Germany*These authors contributed equally to this workCorrespondence: Axel Hage,
Externí odkaz:
https://doaj.org/article/73effe52157e42429e5bc21f9b63c992
Autor:
Stanković Biljana, Kotur Nikola, Gašić Vladimir, Klaassen Kristel, Ristivojević Bojan, Stojiljković Maja, Pavlović Sonja, Zukić Branka
Publikováno v:
Journal of Medical Biochemistry, Vol 39, Iss 4, Pp 488-499 (2020)
Background: Since there are no certified therapeutics to treat COVID-19 patients, drug repurposing became important. With lack of time to test individual pharmacogenomics markers, population pharmacogenomics could be helpful in predicting a higher ri
Externí odkaz:
https://doaj.org/article/f71a4dd590864f428b9fa38cad4a8620
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The coronavirus disease 2019 (COVID-19) is widely spread and remains a global pandemic. Limited evidence on the systematic evaluation of the impact of treatment regimens on antibody responses exists. Our study aimed to analyze the role of antibody re
Externí odkaz:
https://doaj.org/article/6d9aec37863e4e8bb00bea59d0c6dc59
Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2
Publikováno v:
Frontiers in Microbiology, Vol 11 (2021)
SARS-CoV-2 is a newly emerged coronavirus that causes a respiratory disease with variable severity and fatal consequences. It was first reported in Wuhan and subsequently caused a global pandemic. The viral spike protein binds with the ACE-2 cell sur
Externí odkaz:
https://doaj.org/article/3959d7dfcf69472e85cde6b686c820a2
Autor:
Mukarram Jamat Ali, Muhammad Hanif, Muhammad Adnan Haider, Muhammad Umer Ahmed, FNU Sundas, Arham Hirani, Izhan Ali Khan, Khurram Anis, Amin H. Karim
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Background: The recent COVID-19 pandemic sweeping the globe has caused great concern worldwide. Due to the limited evidence available on the dynamics of the virus and effective treatment options available, severe acute respiratory syndrome coronaviru
Externí odkaz:
https://doaj.org/article/3e9490d353a744c98fe4bdff98385053
Autor:
sidhi laksono purwowiyoto
Publikováno v:
Majalah Kardiologi Indonesia, Vol 1, Iss 1 (2020)
Coronavirus Disease 2019 (COVID-19) has spread around the world and become pandemic due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This disease has resulted in significant morbidity and mortality around the world. Reports have s
Externí odkaz:
https://doaj.org/article/25a4822a36fd476eae34d3d227f852b5
Autor:
Adeola Yetunde Olukosi, Muinah Fowora, Adeniyi Kazeem Adeneye, Emelda Chukwu, Oluwagbemiga Aina, Olusola Ajibaye, Ayorinde James, Chidinma Gab-Okafor, Susan Abiodun Holdbrooke, Esther Ngozi Ohihoin, Adesola Zaidat Musa, Olufemi Amoo, Oluyomi Showemimo, Bamgboye Afolabi, Oliver Chukwujekwu Ezechi, Babatunde Lawal Salako
Publikováno v:
African Health Sciences; Vol. 23 No. 1 (2023); 83-92
Background: Rampant chloroquine/hydroxychloroquine poisoning in Nigerian hospitals following suggestions of its possible efficacy in the treatment and prevention of the newly emerged COVID-19 disease informed this survey. Objectives: The aim of this
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maja Stojiljkovic, Biljana Stankovic, Kristel Klaassen, Bojan Ristivojevic, Branka Zukic, Sonja Pavlovic, Vladimir Gasic, Nikola Kotur
Publikováno v:
Journal of Medical Biochemistry, Vol 39, Iss 4, Pp 488-499 (2020)
Journal of Medical Biochemistry (2020) 39(4):488-499
J Med Biochem
Journal of Medical Biochemistry (2020) 39(4):488-499
J Med Biochem
Since there are no certified therapeutics to treat COVID-19 patients, drug repurposing became important. With lack of time to test individual pharmacogenomics markers, population pharmacogenomics could be helpful in predicting a higher risk of develo
Autor:
Signes-Costa J, Nunez-Gil I, Soriano J, Arroyo-Espliguero R, Eid C, Romero R, Uribarri A, Fernandez-Rozas I, Aguado M, Becerra-Munoz V, Huang J, Pepe M, Cerrato E, Raposeiras S, Gonzalez A, Franco-Leon F, Wang L, Alfonso E, Ugo F, Garcia-Prieto J, Feltes G, Abumayyaleh M, Espejo-Paeres C, Jativa J, Masjuan A, Macaya C, Carbonell Asins J, Estrada V, HOPE COVID-19 investigators
Publikováno v:
ARCHIVOS DE BRONCONEUMOLOGIA
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Archivos de Bronconeumología
Archivos De Bronconeumologia
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Archivos de Bronconeumología
Archivos De Bronconeumologia
Patients with pre-existing respiratory diseases in the setting of COVID-19 may have a greater risk of severe complications and even death.A retrospective, multicenter, cohort study with 5847 COVID-19 patients admitted to hospitals. Patients were sepa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f6aee92673b17808e34fbf34abd2bc3
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15406
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15406